A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer.

@article{Sundar2012ASR,
  title={A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer.},
  author={Sudha S Sundar and Jianhua Wu and Kathryn Hillaby and Jason Yap and Richard J. Lilford},
  journal={Gynecologic oncology},
  year={2012},
  volume={125 2},
  pages={
          493-9
        }
}
OBJECTIVE Although overall survival is the ultimate goal of cancer therapy, many clinical and health economic decisions are taken when only progression free survival (PFS) data are available. This study evaluates the relationship between PFS and post progression survival (i.e. the time between disease progression and death) to estimate how many months a new drug for ovarian cancer might add to overall survival if the number of months the drug added to PFS (relative to a standard drug) was… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer.

  • Asian Pacific journal of cancer prevention : APJCP
  • 2014
VIEW 3 EXCERPTS
CITES METHODS & BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

Progression-free survival is a surrogate for survival in advanced colorectal cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007

Similar Papers

Loading similar papers…